INTERCEED TC7 ABSORBABLE ADHESION BARRIER
ETHICON, Inc. · Decision date Sep 15, 1989
What did the FDA approve?
FDA records P880047 as an original PMA application. The recorded decision is approval, dated Sep 15, 1989.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 15, 1989
Regulatory record facts
- Identifier
- P880047
- Regulatory pathway
- Premarket approval application
- Applicant
- ETHICON, Inc.
- Product code
- MCN
- Decision code
- APPR
- Decision date
- Sep 15, 1989
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Barrier, absorbable, adhesion.
- Applicant
- ETHICON, Inc.
- Product code
- MCN
- FDA device class
- 3
FDA decision timeline
P880047 received
Application receipt date recorded by FDA.
P880047 · FDA decision
APPR
P880047/S072 · Related supplement
GYNECARE INTERCEED Absorbable Adhesion Barrier
Timeline entries are records held by MedtechLedger for P880047. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P880047
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
GYNECARE INTERCEED Absorbable Adhesion BarrierP880047/S072 | ETHICON, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Explore the linked device profile
Other records with product code MCN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Juveena Hydrogel SystemP250051/S001 | Rejoni, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Womed LeafP240015/S003 | Womed Sas | PMA supplement | Oct 25, 2026 | FDA |
Juveena Hydrogel SystemP250051 | Rejoni, Inc. | PMA approval | Sep 28, 2026 | FDA |
| Womed Sas | PMA approval | Sep 9, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ETHICON, Inc.
- Headquarters
- Not reported
- Brand website
- ethicon.com
- FDA applicant address
- 1000 Rte. 202, Raritan, NJ, 08869
Sources and methodology
- Original FDA record: P880047
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


